Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The 403 Forbidden page remains unchanged, while its footer revision updates from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T06:58:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T08:14:13.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error screen, preventing access to the study details. The usual page content and navigation are replaced by the error UI, indicating an access restriction rather than actual study information.
    Difference
    16%
    Check dated 2026-09-22T06:37:03.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a new site version deployment. This change appears to be a general platform update rather than content modification to the study record.
    Difference
    0.1%
    Check dated 2026-08-31T23:28:01.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5. This signals a minor update to the page's build or content.
    Difference
    0.1%
    Check dated 2026-08-10T11:51:22.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, representing a new release of the page template/content. This appears to be a routine deployment without changes to study data or primary information.
    Difference
    0.1%
    Check dated 2026-07-27T06:25:41.000Z thumbnail image

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.